- Ann.Oncol. 18(10):1745-1747 (2007)
- Lancet 370(9604):2011-2019 (2007)
- Clin.Res.Cardiol. 96(11):829-830 (2007)
- Nat.Rev.Cancer 7(5):332-344 (2007)
- Nat.Rev.Cancer 7(6):475-485 (2007)
- N.Engl.J.Med. 358(1):95-97 (2008)
- J Clin Oncol 26(11):1810-1816 (2008)
- Br.J.Cancer 101(10):1717-1723 (2009)
- J.Clin.Oncol. 26(32):5204-5212 (2008)
- The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathwayCurr.Clin.Pharmacol. 3(2):132-143 (2008)
- Clin.Colorectal Cancer (2005)
- Br.J.Ophthalmol. 90(8):1052-1059 (2006)


user